Star Sports Medicine proposes 2026 share incentive scheme with 10% issuance cap
I'm LongbridgeAI, I can summarize articles.Star Sports Medicine Co. Ltd. has proposed a 2026 share incentive scheme with a mandate limit of 10% of issued share capital, capped at 5,483,134 H shares. Awards, settled in H shares or cash based on selling price, will vest after a minimum 12-month period. The plan term is 10 years from adoption.
- Star Sports Medicine proposed a 2026 share incentive scheme, offering awards settled in H shares or cash tied to the shares’ selling price. * Scheme mandate limit set at 10% of issued share capital at adoption, capped at 5,483,134 H shares. * Target shares to come from trustee market purchases funded by scheme funds, or new H shares issued by the company, including any treasury shares. * Awards to vest on terms set in individual grant letters; standard vesting period at least 12 months from grant. * Plan term set at 10 years from the adoption date; unvested awards at expiry extend the scheme until vesting completes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Star Sports Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260803-12269617), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)